Last reviewed · How we verify

Canephron® N

Bionorica SE · Phase 3 active Small molecule

Canephron N is a herbal combination that reduces inflammation and supports kidney and urinary tract function through diuretic and antimicrobial properties.

Canephron N is a herbal combination that reduces inflammation and supports kidney and urinary tract function through diuretic and antimicrobial properties. Used for Acute and chronic urinary tract infections, Prevention of recurrent urinary tract infections, Supportive treatment of kidney and bladder conditions.

At a glance

Generic nameCanephron® N
SponsorBionorica SE
Drug classHerbal combination / Phytopharmaceutical
ModalitySmall molecule
Therapeutic areaUrology / Nephrology
PhasePhase 3

Mechanism of action

Canephron N contains a standardized extract of three medicinal plants (Centaurii herba, Levistici radix, and Rosmarini folium) that work synergistically to promote urine flow, reduce urinary tract inflammation, and provide antimicrobial effects. The combination helps alleviate symptoms of urinary tract infections and supports overall renal health through its anti-inflammatory and diuretic mechanisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: